| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/14/2007 | CA2629857A1 Thiadiazole derivatives as antidiabetic agents |
| 06/14/2007 | CA2629819A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795531A1 A thiazolidinedione derivative and its use as antidiabetic |
| 06/13/2007 | EP1795202A1 Preparation for treatment of mineral deficiency |
| 06/13/2007 | EP1795200A1 Medicine and food/beverage for ameliorating hyperglycemia |
| 06/13/2007 | EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1795190A1 Agent for suppressing body fat accumulation |
| 06/13/2007 | EP1794159A1 7-azaindoles and their use as ppar agonists |
| 06/13/2007 | EP1793817A2 Methods of treating a disorder |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | EP0815136B1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 06/13/2007 | CN1981034A Acetyl CoA carboxylase splice variant and uses thereof |
| 06/13/2007 | CN1980930A 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and the use in the form of a DPP-IV inhibitor |
| 06/13/2007 | CN1980912A 吡唑衍生物 Pyrazole derivative |
| 06/13/2007 | CN1980890A Process for the preparation of atorvastatin |
| 06/13/2007 | CN1980686A Antiobesity drug |
| 06/13/2007 | CN1980682A Flaxseeds for body weight management |
| 06/13/2007 | CN1980656A 脂肪酶抑制剂 Lipase inhibitors |
| 06/13/2007 | CN1980655A 脂肪酶抑制剂 Lipase inhibitors |
| 06/13/2007 | CN1980654A Lipase inhibitors |
| 06/13/2007 | CN1978466A Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 06/13/2007 | CN1978445A Compound, and its preparing method and use |
| 06/13/2007 | CN1977975A Inclusion puerarin/cyclodextrin composition and its preparing method |
| 06/13/2007 | CN1977954A Chinese medicine tea bag |
| 06/13/2007 | CN1977938A Bone-invigorating health carefood with effective calcium supplementation and its preparing method |
| 06/13/2007 | CN1977910A Composition for lowering blood cholesterol |
| 06/13/2007 | CN1977898A Chinese medicine for treating cardio-cerebrovascular disease |
| 06/13/2007 | CN1977896A Composition with lipid-reducing function and its preparation and preparing method |
| 06/13/2007 | CN1977884A Medicinal composition for treating diabetes and its preparing method |
| 06/13/2007 | CN1977883A Chinese medicine capsule |
| 06/13/2007 | CN1977866A Poria weight-losing agent |
| 06/13/2007 | CN1977855A Medicinal composition containing mangiferin and its preparing method |
| 06/13/2007 | CN1977844A Pioglitazone and glimepiride compound dropping pill preparation and its preparing method |
| 06/13/2007 | CN1977843A Thiazolidinedione oral sugar-lowering drug dropping pill preparation and its preparing method |
| 06/13/2007 | CN1977842A Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 06/13/2007 | CN1977841A Method for preparing simvastatin tablet |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977676A Preparing of lotus-seed milk health-care drink |
| 06/13/2007 | CN1321133C Human blood high density lipoprotein and its preparation method and use |
| 06/13/2007 | CN1321132C Batyl active peptide, preparation and therepic use thereof |
| 06/13/2007 | CN1321106C New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 06/13/2007 | CN1320925C Long time use compound preparation for treating diabetes |
| 06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
| 06/13/2007 | CN1320888C Polysaccharide biological calcium and its preparation |
| 06/13/2007 | CN1320886C Use of ainfbutamone and anticonvulsant in preparation of treating obesity drug |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230131 Hydrophilic mixture; granulation; drying; diet adjuvants |
| 06/12/2007 | US7230120 Amorphous HMG-CoA reductase inhibitors of desired particle size |
| 06/12/2007 | US7230108 2- or 4-Substituted by a 2-pyridinyl or 2-thiazolyl group, e.g., 2-(2-Chlorobenzyloxy)-4-[N-5-carboxythiazol-2-yl)carbamoyl]-6-methylquinoline; useful in the treatment of type 2 diabetes and obesity |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230024 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230016 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229965 Use of growth hormone in low dose |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229613 Method for lowering serum glucose |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2382581C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/07/2007 | WO2007064757A1 Anti-thymocyte globulin to prevent or delay the onset or the progression on type 1 diabetes |
| 06/07/2007 | WO2007064273A1 Phenyl urea derivatives |
| 06/07/2007 | WO2007064272A1 Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists |
| 06/07/2007 | WO2007064208A1 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063928A1 Novel noncyclic amine carboxamide derivative and salt thereof |
| 06/07/2007 | WO2007063907A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient |
| 06/07/2007 | WO2007063866A1 Novel protein and dna encoding the protein |
| 06/07/2007 | WO2007063648A1 Agent for improving obesity conditions |
| 06/07/2007 | WO2007063551A1 POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(l-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1) |
| 06/07/2007 | WO2007063349A1 Diabetic finished flours or flour mixtures or additive mixtures made from mostly whole-grain and whole-grain cereals |
| 06/07/2007 | WO2007063312A1 Dog diabetes |
| 06/07/2007 | WO2007063095A1 Use of zinc salts of lipoic acid for treating fat metabolism disorders |
| 06/07/2007 | WO2007063012A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 06/07/2007 | WO2007062997A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 06/07/2007 | WO2007062568A1 Compounds used as mammalian cell amp-activated protein kinase(ampk) activators and their preparation methods and usages |
| 06/07/2007 | WO2007062531A1 Combination treatments with gastrin agonists for diabetes and related diseases |